Immune dysfunctions in the elderly result in increased susceptibility to infectious diseases, cancer, and autoimmune diseases. Natural killer (NK) cells are bone marrow-derived lymphocytes crucial for host defense against several infections and cancer. We have previously shown that compared to young, aged C57BL/6 mice have decreased numbers of mature NK cells in the blood, spleen, and bone marrow, resulting in susceptibility to mousepox, a lethal disease caused by ectromelia virus. Here, we describe further age-related defects in NK cells including reduced proliferation in vivo, additional signs of immaturity, and dysregulated expression of activating and inhibitory receptors. Aging also alters the expression of collagen-binding integrins in conventional NK cells and the frequency and phenotype of liver tissueresident NK cells. We additionally show that the defect in NK maturation is the consequence of deficient maturational cues provided by bone marrow stromal cells. Moreover, we demonstrate that in aged mice, treatment with complexes of the cytokine IL-15 and IL-15Ra induce massive expansion of the NK cells, but most of these NK cells remain immature and are unable to restore resistance to mousepox. The use of rodent model to understand immunosenescence may help the development of treatments to improve the immune fitness of the aged. Our work with NK cells should contribute toward this goal.
Introduction
The elimination of viruses and resistance to viral diseases requires the coordinated action of both the innate and adaptive immune system. It is well established that the aged are generally more susceptible than the young to viral infections (Leng & Goldstein, 2010; Nikolich-Zugich et al., 2012) , which has generally been ascribed to intrinsic defects in adaptive T-cell responses. Hence, much of the current efforts in the research of antiviral immunity of the aged are geared to understanding this process.
On the other hand, less is known about specific defects in innate immunity of the aged.
NK cells are innate lymphocytes that produce cytokines such as IFN-c and kill infected and tumor cells. In humans, NK cells are critical for resistance to several viral infections (Orange, 2002; Sun & Lanier, 2011) such as Epstein-Barr virus, human cytomegalovirus, varicella-zoster virus, and herpes simplex virus. In mice, NK cells are essential for resistance to mouse cytomegalovirus (Bukowski et al., 1984; Loh et al., 2005) and the agent of mousepox, ectromelia virus (ECTV) (Delano & Brownstein, 1995; Fang et al., 2008) .
NK cells develop mostly in the bone marrow from hematopoietic stem cell precursors that interact with stromal cells to progressively mature and acquire effector functions (Colucci et al., 2003 respectively (Hayakawa & Smyth, 2006) . NK cells express several inhibitory receptors (e.g. Ly49A, Ly49C, Ly49G2, and KLRG1) that maintain NK cell self-tolerance and license their effector functions, and activating receptors (e.g. NK1.1, Ly49D, Ly49H, NKG2D, NKp46) that recognize ligands on target cells to trigger cytolysis and effector cytokine production (Lanier, 2005) . The different inhibitory and activating receptors are acquired at defined stages of the NK cell developmental process, and defects in maturation can affect their expression (Kim et al., 2002) .
In addition to activating and inhibitory receptors, other molecules are differentially expressed during NK cell maturation. For example, surface expression of the chemokine receptor CXCR3 is more prominent in immature than in mature NK cells (Marquardt et al., 2010) .
The exit of NK cells from the bone marrow and their migration into tissues is crucial for immune surveillance. Integrins are vital in cell-cell and cell-extracellular matrix interactions, cellular differentiation, and cell trafficking (Hood & Cheresh, 2002) . A very characteristic integrin of NK cells is CD49b (a2, recognized by mAb DX5), which is usually used to enumerate NK cells in mouse strains such as BALB/c, 129, and DBA/2 (Arase et al., 2001 ) that lack reactivity with the anti-NK1.1 mAb PK136 due to allelic polymorphisms in the Nkrp1b/c genes (Giorda et al., 1992; Carlyle et al., 2006) . CD49b is expressed in maturing NK cells right before CD11b (Kim et al., 2002) . It pairs with the integrin CD29 (b1) to form a collagen receptor with preference for collagens type I and III (Leitinger & Hohenester, 2007) . The bone marrow also contains a small population of immature NK cells that are CD49b
À (Kim et al., 2002) .
These cells are different from tissue-resident NK (trNK) cells, abundant in liver sinusoids, which are also CD49b À but express the integrin CD49a (a1) (Peng et al., 2013; Sojka et al., 2014 ) that also pairs with b1 but to preferentially bind collagen type IV and VI (Leitinger & Hohenester, 2007) Different to immature CD49b À cells in the bone marrow, trNK cells in the liver also express the TNF-related apoptosis-inducing ligand (TRAIL) and are cytotoxic. Moreover, they originate from liver-specific hematopoietic progenitor cells (HPCs) and not from bone marrow precursors (Peng et al., 2013; Sojka et al., 2014) .
Blood cell development is regulated by transcription factors (TF). Tbet and Eomesodermin (Eomes) are TFs of the T-box family that play an important role in NK cell development and maturation (Gordon et al., 2010; Daussy et al., 2014; Sojka et al., 2014 (Daussy et al., 2014; Sojka et al., 2014) .
The development and proliferation of NK cells is critically dependent on the cytokine IL-15 which is produced by bone marrow stromal cells (Cui et al., 2014) . IL-15 is recognized through the IL-15 receptor which is a trimer formed by the soluble IL-15Ra chain together with membranebound b and c chains of the IL-2 receptor. IL-15 and its receptor IL-15Ra are important for NK cell development and survival (Marcais et al., 2013) . Mice deficient in IL-15 or the IL-15Ra are deficient in NK cells (Lodolce et al., 1998; Kennedy et al., 2000) . Further, treatment of mice with IL-15 or IL-15/IL-15Ra complexes has been shown to induce NK cell proliferation in young mice (Rubinstein et al., 2006; Stoklasek et al., 2006; Dubois et al., 2008; Elpek et al., 2010) .
We have previously shown that under homeostatic conditions, aged B6 mice have decreased maturation of NK cells in the blood, spleen, lymph nodes, and bone marrow and that this results in impaired migration of NK cells to the draining lymph node (D-LN) and susceptibility to mousepox (Fang et al., 2010) . The defective maturation of NK cells in aged mice has recently been confirmed by other groups (Chiu et al., 2013; Beli et al., 2014) . In addition to defective maturation, NK cells show loss of NK cell-mediated cytotoxicity and IFN-c production in both aged humans and mice (Albright & Albright, 1983; Nogusa et al., 2008; Fang et al., 2010; Hazeldine et al., 2012; Solana et al., 2012) . However, the specific mechanisms that underlie these defects remain unknown.
Here, we show that the NK cells of aged mice have multiple maturation defects including reduced proliferation in vivo, multiple signs of immaturity, altered expression of activating and inhibitory receptors, and, intriguingly, altered expression of collagen-binding integrins. We also show that the defect in NK maturation is the consequence of deficient maturational cues provided by bone marrow stromal cells. Moreover, we also show that treatment with complexes of the cytokine IL-15 and IL-15Ra induced massive expansion of the NK cells in aged mice, but most of these NK cells remain immature and are unable to provide resistance to mousepox.
Results

Aged mice have increased frequency of immature NK cells with poor proliferative potential
We have previously shown that compared to young, aged B6 mice have lower frequencies of mature CD27 À CD11b + NK cells in the bone marrow and spleen (Fang et al., 2010) . Confirming this, aged mice had a significant increase in the frequency of immature CD27 + CD11b À and a significant decrease in mature CD27 À CD11b + NK cells in the bone marrow ( Fig. 1A) and spleen (Fig. 1B) . We also found that in the bone marrow, total, and more specifically nonterminally differentiated CD27 + CD11b À and CD27 + CD11b + NK cells proliferated significantly less in aged than in young mice as measured by BrdU incorporation (Fig. 1C) . In the spleen, there were no significant differences in the proliferative capacity of total NK cells, but there was significantly reduced proliferation of immature CD27 + CD11b À and increased (albeit low) proliferation of mature CD27 À CD11b + NK cells in aged mice (Fig. 1D) . Our results are in agreement with a recent study reporting that aged bone marrow has a reduced frequency of proliferating immature NK cells (Beli et al., 2014) . The increased frequency and reduced proliferation of immature NK cells in the bone marrow of aged mice suggest that full maturation requires proliferation.
NK cells in aged mice display additional signs of immaturity
Our data and that of others (Chiu et al., 2013; Beli et al., 2014) show NK cell development is hampered in aged mice. To confirm and extend these results, we stained bone marrow and spleens of young and aged B6 mice with mAbs to molecules whose expression is known to be regulated during NK cell maturation. NK cells expressing the inhibitory receptor KLRG1, which is normally expressed in the most mature NK cells (Huntington et al., 2007) (Fig. 3A) , which under normal conditions, mostly stains inhibitory NKG2A in NK cells (Vance et al., 1999) . In the spleen, total NK cells of aged mice had decreased expression of activating Ly49D (Fig. 3B ) and Ly49H ( Fig. 3C ) and increased expression of inhibitory Ly49A (Fig. 3D ). When maturational subpopulations were analyzed, the expression of Ly49H was increased in immature CD27 + CD49b
À , Ly49D and Ly49H were reduced in the more mature subsets (Fig. 3B and C) , and the increase in Ly49A expression was only observed in the immature CD27 + CD11b À subset (Fig. 3D) activating and inhibitory receptors in the bone marrow and spleen of aged mice, a discernible pattern was not found.
NK cells in aged mice have altered expression of collagenbinding integrins
We have previously shown that NK cells in aged mice fail to migrate to lymph nodes in response to ECTV infection (Fang et al., 2010) . It is well established that the integrin a2 (CD49b, recognized by mAb DX5) is expressed in conventional NK cells starting at a stage right before the expression of the integrin CD11b (Kim et al., 2002) Natural killer cell dysfunction in aged mice, S. Nair et al.
described in the liver (Daussy et al., 2014; Sojka et al., 2014) , because they were TRAIL À Eomes + (data not shown).
To form collagen receptors, CD49b and CD49a pair with the integrin b1 (CD29) (Leitinger & Hohenester, 2007 The defect in the maturation of NK cells in aged mice is due to the aged bone marrow stroma NK cells are generated from radio-sensitive hematopoietic precursors mostly in the bone marrow environment that is composed of radioresistant mesenchymal stromal cells (Colucci et al., 2003) . To determine whether the NK cell maturation defect in aged mice was due to deficiencies in the hematopoietic precursors or in the stromal cell compartment, we made bone marrow chimeras by sublethally irradiating young and aged B6 mice (CD45.2) and reconstituting them with a 1:1 mixture of bone marrow cells from aged B8-Ly5.2Cr (B6-CD45.1) and young GFP transgenic B6 (B6-GFP, CD45.2) mice that had been depleted of NK cells (Fig. 5A) Treatment of aged mice with IL-15/IL-15Ra complexes induces a massive expansion of immature NK cells that do not restore resistance to mousepox
Combined treatment of IL-15 and its receptor IL-15Ra in mice markedly enhances NK proliferation in vivo (Rubinstein et al., 2006; Stoklasek et al., 2006; Dubois et al., 2008; Elpek et al., 2010) . Accordingly, when we treated aged mice with IL-15/IL-15Ra complexes, we found a significant increase in the frequency of total NK cells in the bone marrow and spleen (Fig. 6A) (Fig. 6C and D) . Together, these data suggest that in aged mice, IL-15/IL-15Ra increases the number of NK cells by stimulating the production of immature NK cells but does not promote P-values were calculated using Mann-Whitney U statistical tests. Data correspond to two independent experiments combined. Each data point represents an individual mouse. In all the panels, n = 10 except spleen where the young group had nine mice.
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Bone marrow their maturation. We have previously shown that aged B6 mice are susceptible to mousepox due to decreased number and maturation of NK cells (Fang et al., 2010 ). Thus, we tested whether the massive increase in total NK cells induced by IL-15/IL-15Ra complex could improve the resistance of aged B6 mice to mousepox. However, increased resistance did not occur (Fig. 6E) . This is consistent with the 4 NK cells in aged mice show differential expression of collagen-binding integrins. Cells from bone marrow, spleens, and livers of young or aged mice were stained with mAbs to NK1.1, CD3e, CD27, CD11b, CD49b, CD49a, TRAIL and CD29 (bone marrow and spleen) and analyzed by flow cytometry as in Fig. 1. (A (A-C) n = 13 mice. (D) n = 8 mice. (E.1-E.4) young (n = 8) and aged (n = 9) mice. (E.5-E.6) young (n = 9) and aged (n = 8) mice.
Natural killer cell dysfunction in aged mice, S. Nair et al. finding that the mature NK cells are those involved in resistance to mousepox (Fang et al., 2010 (Fang et al., , 2011 and show that even very large numbers of immature NK cells cannot protect from mousepox.
Discussion
While it is now well established that in mice and humans NK cells become dysfunctional with age (Albright & Albright, 1983; Nogusa et al., 2008; Fang et al., 2010; Hazeldine et al., 2012; Solana et al., 2012) , the whole scope of the dysfunctions and the underlying mechanisms remain unknown. Here, we characterized the impairment of NK cells of aged mice to a greater extent than before, demonstrated that the origin of the defect is in the stroma of the bone marrow, and showed that the maturation and antiviral competence of the NK cells cannot be restored by treating aged mice with IL-15/IL-15Ra. + NK cells. P-values were calculated using Tukey's test after one-way ANOVA. In (A-D) , the data are representative of two independent experiments combined where young (n = 4), aged (n = 8), and aged + treatment (n = 7) mice. (E) Mice were infected with 3000 pfu of ECTV in the footpad and monitored for survival. For humane reasons, the experiment was performed only one time (n = 5).
Natural killer cell dysfunction in aged mice, S. Nair et al. We have previously reported a decreased number of total NK cells in the blood and spleen and reduced frequencies of CD27 À CD11b + mature NK cells in the blood, spleen, lymph nodes, and bone marrow of aged mice. Further, we showed that this defect resulted in the loss of resistance to lethal mousepox (Fang et al., 2010) . Here, we expanded this finding by demonstrating that immature NK cells in the aged mice proliferate poorly, have additional characteristics of immature cells including decreased KLRG1 and increased CXCR3 expression, and dysregulated expression of Eomes and several inhibitory and activating receptors. Age-associated alterations in the frequency of NK cells, alteration of cell surface receptors, and loss of NK function have been previously observed in both mice and humans (Solana et al., 2012) . Consistent with our results, others have also recently shown decreased frequencies of KLRG1 + (Chiu et al., 2013; Beli et al., 2014) and increased frequencies of CXCR3 + NK cells in aged mice (Beli et al., 2014) . We also observed an age-associated decrease in Eomes in the more mature NK cell population. Expression of activating and inhibitory receptors was also altered with aging, but the reason and functional consequences of these changes remain to be elucidated. Intriguingly, we found that aged mice have altered expression of collagen-binding integrins with decreased expression of CD49b and CD29, and increased expression of CD49a in total NK cells and in different NK cell maturation subsets as defined by their expression of CD27 and CD11b in the bone marrow and spleen. Of note, in aged mice, most of the CD49b À NK cells in the spleen are also CD49a (Feng et al., 2006) . More interestingly, it has been recently shown that CD49b and its interaction with collagen fibers regulates the motility and localization of NK cells in lymph nodes during Toxoplasma gondii infection (Coombes et al., 2012) . As we previously reported, NK cells in aged mice fail to migrate to the D-LN following ECTV infection due to cell intrinsic defects (Fang et al., 2010 (Daussy et al., 2014; Sojka et al., 2014) . While the role of hepatic trNK cells remains mostly unexplored, it has recently been shown that they produce memorylike response in NK cell-mediated contact hypersensitivity (Peng et al., 2013) . Whether they play a role in resistance to viral infections and contribute to the enhanced susceptibility of aged mice to lethal mousepox should be explored further. Our analysis of mixed bone marrow chimeras showed that the deficiencies of the NK cells in aged mice are not due to intrinsic defects of the hematopoietic precursors but due to an inadequate stroma. A similar observation has just been made by another group (Chiu et al., 2013) . A characteristic of aging is the decline of lymphopoiesis and an increase in myelopoiesis. The main mesenchymal cell types in the bone marrow that regulate hematopoiesis are osteoblasts and adipocytes. Osteoblasts are essential for lymphopoiesis, while bone marrow adipocytes are known to suppress lymphopoiesis and promote myelopoiesis. Moreover, a deficit in osteoblasts results in decreased numbers of hematopoietic stem cells in the bone marrow. Increased bone marrow adipogenesis and decreased proliferation and maintenance of osteoblasts are characteristics of aging (Chinn et al., 2012) . It is known that age-associated changes in the bone marrow stroma decrease the differentiation of pro-B into pre-B cells and result in reduced expression of rag2 and V(D)J recombinase activity in pro-B cells (Labrie et al., 2005) . Our data show that developmental defects in NK cells of the aged are due to deficiencies in the mesenchymal stromal cells of bone marrow but not due to the hematopoietic stem cells. Notably, the mesenchymal stromal cells are responsible for the production of type I and type IV collagen in the bone marrow (Waterhouse et al., 1986) . Our data showed that NK cells in aged mice have low expression of a2b1 (CD49b CD29) integrin, receptor for type I collagen with reciprocal increases in expression of a1b1 (CD49a CD29) integrin, and receptor for type IV collagen. Whether these findings are causally related and whether the interaction of developing NK cells with collagen in the bone marrow is required for proper NK cell maturation need to be further explored.
The mesenchymal stromal cells in the bone marrow are also major producers of IL-15 (Cui et al., 2014) , a cytokine that is essential for the development of NK cells (Marcais et al., 2013) . It has also been shown that when administered as a complex with IL-15Ra, the half-life and bioavailability of IL-15 in vivo are increased, resulting in a massive expansion of the NK cell pool (Rubinstein et al., 2006; Stoklasek et al., 2006; Dubois et al., 2008; Elpek et al., 2010) . It was therefore plausible to hypothesize that the defect of NK cells in aged mice could arise from defective IL-15 production in the bone marrow and that their numbers and maturation could be increased by IL-15/IL-15Ra treatment. However, while we found that IL-15/IL-15Ra treatment did increase the frequency of NK cells in aged mice significantly, the frequency of mature NK cells was actually reduced. Furthermore, IL-15/IL-15Ra treatment did not restore resistance to mousepox, indicating that the functionality of the NK cells in treated mice was not restored. Consistent with our results, Chiu et al. (2013) recently showed that treatment of aged mice with IL-15/IL-15Ra increases the frequency of NK cells as well as the expression of KLRG1 and the cytolytic activity of NK cells, suggesting that IL-15/IL-15Ra treatment could be used therapeutically to restore full functionality to the NK cell compartment of the aged. However, they did not determine the effect of IL-15/IL15Ra in the frequency of the different NK cell maturation subsets as determined by CD27 and CD11b expression or the NK cell protective function during a pathogenic infection. Our results demonstrating that IL-15/IL-15Ra treatment does not increase the functionally relevant CD27 À CD11b + compartment and does not recover resistance to mousepox indicate that this treatment may not be sufficient to restore a fully functional NK cell compartment in the aged and that additional treatments should be explored.
Experimental procedures Mice
The Fox Chase Cancer Center (FCCC) Institutional Animal Care and Use Committee approved the experimental protocols involving animals. Female mice were used for all the experiments. C57BL/6 (CD45.2) mice were purchased from Taconic when they were 6-8 weeks old. Breeders of C57BL/6-Tg(CAG-EGFP)1Osb/J (B6-GFP, CD45.2) mice were purchased from Jackson Laboratories and bred at FCCC. Aged B6 (CD45.2) mice were purchased young from Taconic and aged at FCCC or were purchased as aged from the National Institute of Aging. B6-Ly5.2/Cr (B6-CD45.1) were purchased young from the National Cancer Institute and aged at FCCC. In all experiments, young mice were 6-8 weeks old, while aged mice were 15-18 months old. All purchased mice were rested at least 1 week in the FCCC animal facility before use.
Viruses and infections
ECTV stocks were produced and titers determined as previously described (Fang et al., 2010 (Fang et al., , 2011 . Mice were infected in the left footpad with 25 ll PBS containing 3 9 10 3 pfu ECTV.
Cell isolation
Mice were euthanized by cervical dislocation. Single-cell suspensions were prepared from spleen and bone marrow and lysed for red blood cells (RBCs) using Ammonium-Chloride-Potassium (ACK) lysis buffer, and cells were washed with RPMI 1640 supplemented with 5% FCS and later used for flow cytometric analysis. To obtain liver mononuclear cells, anesthetized mice were bled by cardiac puncture, and the liver was isolated, mechanically dissociated with plunger on a 100-lm cell strainer, and filtered through a 70-lm cell strainer. The single-cell suspension was washed once with RPMI media and spun at 524 g for 10 mins at 4°C. The pellet was resuspended in 40% percoll containing 100 U/ml of heparin, centrifuged for 20 min at 931 g at room temperature, and the RBCs were lysed with ACK, washed with RPMI, and used for flow cytometric analysis.
Mixed bone marrow chimeras
Young GFP transgenic B6 mice (CD45.2) and aged B6 congenic B6.CD45.1 mice were depleted of NK cells by intraperitoneal administration of 200 lg of PK136 antibody. Two days later, bone marrow cells from the NK-depleted donors were collected, mixed (1:1), and 6 9 10 6 used to reconstitute young and aged B6 (CD45.2) recipient mice that had been irradiated with 600 Rad. 45 days later, the frequency of mature NK cells (CD27 À CD11b + ) among total NK cells was measured in the bone marrow of young or aged recipients.
BrdU incorporation assay
Mice were injected with 2 mg BrdU i.p. 16 h later, and spleens and bone marrow were removed and made into single-cell suspensions. The cells were stained for cell surface molecules, fixed, and permeabilized using the Cytofix/Cytoperm kit, incubated with DNase at 37°C for 1 h, stained with anti-BrdU mAb, and analyzed for intracellular BrdU incorporation in total NK cells and subsets.
IL-15/IL-15Ra treatment
For each treatment, 0.5 lg of recombinant human IL-15 (R&D Systems, Minneapolis, MN, USA) and 3 lg of recombinant murine IL-15Ra Fc chimera (R&D Systems) were mixed and incubated for 30 min at 37°C. Aged B6 mice were inoculated intraperitoneally with the IL-15/IL-15Ra complex every other day for a period of 2 weeks (Elpek et al., 2010) .
Flow cytometry
Flow cytometry was performed as previously described Fang et al. (2010) . The following antibodies were used: anti-CD3e (clone 145-2C11, Biolegend), anti-CD11b (clone M1/70, Biolegend), anti-CD19 (clone 1D3, BD Biosciences), anti-CD27 (clone LG.3A10, Biolegend), anti-CD29 (clone HMb1-1, Biolegend San Diego, CA), anti-CD44 (clone IM7, Biolegend), anti-CD45.1 (clone A20, Biolegend), anti-CD45.2 (clone 104, Biolegend), anti-CD49a (clone HMa1, Biolegend), anti-CD49b (clone DX5, Biolegend), anti-CD105 (clone MJ7/18, Biolegend), anti-CD106 (clone 429, Biolegend), anti-BrDU (clone PRB-1, eBioscience), anti-CXCR3 (clone CXCR3-173, Biolegend), anti-Eomes (clone Dan11mag, eBioscience), anti-KLRG1 (clone 2F1/KLRG1, Biolegend), anti-Ly-6A/E (Sca-1) (clone E13-161.7, Biolegend), anti-Ly49A (clone A1/Ly49A, Biolegend), anti-Ly49C/I (clone 5E6, Biolegend), anti-Ly49D (clone 4E5, Biolegend), anti-Ly49G2 (clone LGL-1, eBioscience), anti-Ly49H (clone 3D10, Biolegend), anti-NK1.1 (clone PK136, Biolegend), NKG2A/C/E (clone 20d5, Biolegend), anti-Tbet (clone 4B10, Biolegend), and anti-TRAIL (clone N2B2, Biolegend). At least 500 000 cells were analyzed by flow cytometry at the Fox Chase Cell Sorting Facility using an LSR II system (BD Biosciences).
Statistical analysis
Statistical analysis was performed with Prism software (Graphpad Software Inc., La Jolla, CA, USA) software. For survival studies, P-values were obtained with the log-rank (Mantel-Cox) test. P-values were determined using Mann-Whitney test, and when multiple groups had to be compared, we used one-way ANOVA and post-hoc Tukey's for multiple comparisons.
